POLYVALENT MELANOMA VACCINE IMPROVES SURVIVAL OF PATIENTS WITH METASTATIC MELANOMA

被引：0
|
作者：
MORTON, DL [1 ]
HOON, DSB [1 ]
NIZZE, JA [1 ]
FOSHAG, LJ [1 ]
FAMATIGA, E [1 ]
WANEK, LA [1 ]
CHANG, C [1 ]
IRIE, RF [1 ]
GUPTA, RK [1 ]
ELASHOFF, R [1 ]
机构：
[1] ST JOHNS HOSP, SANTA MONICA, CA 90404 USA
来源：
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 1993年 / 690卷
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：120 / 134
页数：15
相关论文
共 50 条
  • [1] Novel vaccine improves survival in metastatic melanoma
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (07) : 379 - 379
  • [2] PROLONGATION OF SURVIVAL IN METASTATIC MELANOMA AFTER ACTIVE SPECIFIC IMMUNOTHERAPY WITH A NEW POLYVALENT MELANOMA VACCINE
    MORTON, DL
    FOSHAG, LJ
    HOON, DSB
    NIZZE, JA
    WANEK, LA
    CHANG, C
    DAVTYAN, DG
    GUPTA, RK
    ELASHOFF, R
    IRIE, RF
    ANNALS OF SURGERY, 1992, 216 (04) : 463 - 482
  • [3] IMPROVED SURVIVAL OF PATIENTS WITH MELANOMA WITH AN ANTIBODY-RESPONSE TO IMMUNIZATION TO A POLYVALENT MELANOMA VACCINE
    MILLER, K
    ABELES, G
    ORATZ, R
    ZELENIUCHJACQUOTTE, A
    CUI, J
    ROSES, DF
    HARRIS, MN
    BYSTRYN, JC
    CANCER, 1995, 75 (02) : 495 - 502
  • [4] Ipilimumab improves survival in metastatic melanoma patients
    Hodi, F. S.
    O'Day, S. J.
    McDermott, D. F.
    IMMUNOTHERAPY, 2011, 3 (08) : 928 - 929
  • [5] Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine
    Vilella, R
    Benitez, D
    Milà, J
    Vilalta, A
    Rull, R
    Cuellar, F
    Conill, C
    Vidal-Sicart, S
    Costa, J
    Yachi, E
    Palou, J
    Malvehy, J
    Puig, S
    Marti, R
    Mellado, B
    Castel, T
    INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (04) : 626 - 631
  • [6] IMMUNOGENICITY OF A POLYVALENT MELANOMA ANTIGEN VACCINE IN PATIENTS WITH EARLY MELANOMA
    BYSTRYN, JC
    LONBERG, M
    BERNSTEIN, P
    HARRIS, M
    ROSES, D
    SPEYER, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 312 - 312
  • [7] Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients?
    Hoon, DSB
    Okamoto, T
    Wang, HJ
    Elashoff, R
    Nizze, AJ
    Foshag, LJ
    Gammon, G
    Morton, DL
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1430 - 1437
  • [8] TREATMENT OF MELANOMA WITH A POLYVALENT MELANOMA ANTIGEN VACCINE
    BYSTRYN, JC
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1985, 11 (08): : 775 - 776
  • [9] Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine
    Hsueh, EC
    Gupta, RK
    Qi, K
    Morton, DL
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) : 2913 - 2920
  • [10] Long-term survival of stage IV melanoma patients treated with a polyvalent, shed antigen, melanoma vaccine
    Laky, D
    Shapiro, RL
    Harris, MN
    Roses, DF
    Jacquotte, AZ
    Reynolds, SR
    Bystryn, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 240 - 240
12345